ORG Wealth Partners
MRNA icon

ORG Wealth Partners’s Moderna MRNA Stock Holding History

ORG Wealth Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$991K Buy
+5,146
New +$555K 0.16% 97

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $2.62B AUM 125.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

ORG Wealth Partners's MRNA Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Moderna (MRNA) in Q3 2026: 5,146 shares worth $991K. The stake represents 0.16% of the portfolio and ranks #97 among its holdings.

858 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • ORG Wealth Partners held 5,146 shares of Moderna worth $991K as of Q3 2026.
  • Moderna was a new ORG Wealth Partners position in Q3 2026.
  • Moderna made up 0.16% of ORG Wealth Partners's portfolio in Q3 2026, its #97 holding.
  • 858 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.